Ran An Selected Research

Vaccines

2/2024	Protective effect against toxoplasmosis in BALB/C mice vaccinated with recombinant Toxoplasma gondii CDPK3, GRA35, and ROP46 protein cocktail vaccine.
1/2023	Imprinted SARS-CoV-2 humoral immunity induces convergent Omicron RBD evolution.
8/2022	Live-attenuated ME49Δcdpk3 strain of Toxoplasma gondii protects against acute and chronic toxoplasmosis.
5/2022	Self-assembled BPIV3 nanoparticles can induce comprehensive immune responses and protection against BPIV3 challenge by inducing dendritic cell maturation in mice.
1/2022	BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection.
1/2021	Protective Effect Against Toxoplasmosis in BALB/c Mice Vaccinated With Recombinant Toxoplasma gondii MIF, CDPK3, and 14-3-3 Protein Cocktail Vaccine.
11/2019	Vaccination with recombinant Toxoplasma gondii CDPK3 induces protective immunity against experimental toxoplasmosis.
1/2019	Protective Effect Against Toxoplasmosis in BALB/c Mice Vaccinated With Toxoplasma gondii Macrophage Migration Inhibitory Factor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ran An Research Topics

Disease

36	Neoplasms (Cancer) 02/2024 - 01/2008
17	Infections 03/2024 - 11/2019
14	Inflammation (Inflammations) 05/2024 - 01/2018
14	Sickle Cell Anemia (Hemoglobin S Disease) 02/2023 - 01/2020
8	Pain (Aches) 02/2024 - 01/2018
6	Toxoplasmosis 02/2024 - 01/2019
5	Breast Neoplasms (Breast Cancer) 01/2023 - 07/2019
5	Parkinson Disease (Parkinson's Disease) 02/2018 - 01/2015
4	Fibrosis (Cirrhosis) 01/2024 - 08/2019
4	Postoperative Pain 01/2024 - 01/2021
4	Anemia 10/2023 - 01/2021
4	Stroke (Strokes) 10/2023 - 09/2016
4	Hemolysis 01/2023 - 01/2018
4	Melanoma (Melanoma, Malignant) 01/2023 - 01/2022
4	Lung Neoplasms (Lung Cancer) 01/2022 - 10/2019
3	Rectal Neoplasms (Rectal Cancer) 05/2024 - 01/2023
3	Adenocarcinoma 03/2024 - 05/2018
3	Cysts 02/2024 - 01/2021
3	Cognitive Dysfunction 01/2024 - 05/2015
3	Reperfusion Injury 10/2023 - 10/2017
3	Hypoxia (Hypoxemia) 10/2023 - 01/2023
3	Hepatocellular Carcinoma (Hepatoma) 10/2023 - 10/2018
3	Hemorrhage 10/2023 - 10/2022
3	Ovarian Neoplasms (Ovarian Cancer) 08/2023 - 01/2013
3	Insulin Resistance 01/2023 - 10/2019
3	Neoplasm Metastasis (Metastasis) 01/2023 - 01/2010
3	Wounds and Injuries (Trauma) 10/2022 - 05/2015
3	Obesity 08/2022 - 03/2020
3	Osteoporosis 03/2022 - 06/2015
3	Hyperlipidemias (Hyperlipidemia) 09/2021 - 05/2015
2	Alzheimer Disease (Alzheimer's Disease) 04/2024 - 01/2019
2	Liver Cirrhosis (Hepatic Cirrhosis) 01/2024 - 08/2019
2	Atrophy 01/2024 - 04/2021
2	Tetralogy of Fallot (Fallot Tetralogy) 10/2023 - 01/2022
2	Hypertension (High Blood Pressure) 10/2023 - 09/2014
2	Breakthrough Infections 01/2023 - 11/2022
2	Postoperative Nausea and Vomiting (PONV) 01/2023 - 01/2021
2	Liver Neoplasms (Liver Cancer) 07/2022 - 01/2020
2	Carcinogenesis 01/2022 - 10/2019
2	Non-alcoholic Fatty Liver Disease 01/2022 - 03/2020

Drug/Important Bio-Agent (IBA)

13	Proteins (Proteins, Gene)FDA Link 02/2024 - 10/2017
11	CytokinesIBA 02/2024 - 10/2018
9	Biomarkers (Surrogate Marker)IBA 01/2024 - 06/2020
8	VaccinesIBA 02/2024 - 01/2019
6	Neutralizing AntibodiesIBA 01/2023 - 01/2019
6	TeaIBA 07/2022 - 05/2019
5	AntibodiesIBA 02/2024 - 01/2019
5	Oxygen (Dioxygen)IBA 12/2023 - 10/2017
5	LipidsIBA 01/2022 - 01/2018
4	Reactive Oxygen Species (Oxygen Radicals)IBA 02/2024 - 01/2008
4	Therapeutic UsesIBA 01/2024 - 09/2014
4	Hemoglobins (Hemoglobin)IBA 10/2023 - 01/2021
4	Indicators and Reagents (Reagents)IBA 02/2023 - 02/2017
4	Capsules (Microcapsules)IBA 09/2021 - 05/2015
3	Anti-Bacterial Agents (Antibiotics)IBA 04/2024 - 01/2021
3	Glucose (Dextrose)FDA LinkGeneric 12/2023 - 10/2017
3	Monoclonal AntibodiesIBA 11/2023 - 11/2021
3	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2023 - 11/2020
3	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2023 - 08/2022
3	Laminin (Merosin)IBA 01/2023 - 11/2020
3	N-methyl-valyl-amiclenomycin (BA 2)IBA 01/2023 - 01/2022
3	AcidsIBA 01/2023 - 06/2017
3	PorphyrinsIBA 12/2022 - 01/2008
3	AntioxidantsIBA 02/2021 - 05/2015
3	ATP-Binding Cassette Transporters (ABC Transporters)IBA 02/2009 - 01/2008
2	Eosine Yellowish-(YS) (Eosin)IBA 03/2024 - 01/2022
2	Hematoxylin (Haematoxylon)IBA 03/2024 - 01/2022
2	Amyloid (Amyloid Fibrils)IBA 01/2024 - 01/2019
2	CollagenIBA 12/2023 - 01/2020
2	RNA (Ribonucleic Acid)IBA 12/2023 - 10/2019
2	EpitopesIBA 11/2023 - 01/2022
2	InflammasomesIBA 10/2023 - 01/2021
2	Tumor Biomarkers (Tumor Markers)IBA 10/2023 - 01/2021
2	Cisplatin (Platino)FDA LinkGeneric 08/2023 - 01/2013
2	AlginatesIBA 03/2023 - 06/2022
2	Macrophage Migration-Inhibitory FactorsIBA 01/2023 - 01/2019
2	Blood Glucose (Blood Sugar)IBA 01/2023 - 08/2022
2	Sickle HemoglobinIBA 01/2023 - 04/2020
2	Insulin (Novolin)FDA Link 01/2023 - 08/2022
2	Analgesics (Analgesic Drugs)IBA 01/2023 - 01/2018
2	LigandsIBA 01/2023 - 07/2019
2	N-(2-cyanoethylene)urea (BA 1)IBA 11/2022 - 01/2022
2	IronIBA 03/2022 - 02/2021
2	skullcapflavone IIBA 01/2022 - 10/2019
2	MicroRNAs (MicroRNA)IBA 01/2022 - 08/2016
2	Fibrinogen (Factor I)FDA Link 01/2022 - 11/2020
2	Protein Isoforms (Isoforms)IBA 12/2021 - 11/2020
2	SulfonamidesIBA 12/2021 - 11/2020
2	Tyrosine Kinase InhibitorsIBA 11/2021 - 01/2010

Therapy/Procedure

25	Therapeutics 03/2024 - 02/2017
5	Drug Therapy (Chemotherapy) 11/2021 - 01/2010
4	Neoadjuvant Therapy 03/2024 - 01/2023
3	Immunotherapy 05/2024 - 01/2023
3	Aftercare (After-Treatment) 04/2024 - 01/2018
3	Radiotherapy 02/2024 - 10/2015
3	Transplantation 10/2023 - 01/2022
3	Chinese Traditional Medicine (Traditional Chinese Medicine) 03/2022 - 05/2015
2	Lymph Node Excision (Lymph Node Dissection) 01/2024 - 04/2021
2	Glycemic Control 08/2022 - 01/2019
2	Ovariectomy (Oophorectomy) 03/2022 - 04/2021